3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuralgia
1
Neoplasms
1
Leiomyoma
1
Hot Flashes
1
Carcinoma, Hepatocellular
1
Interventions
estradiol, norethindrone drug combination
9
asoprisnil
9
Uterine Myomectomy
9
telapristone acetate
8
Uterine Artery Embolization
8
ulipristal acetate
7
relugolix
7
elagolix
7
Estradiol
7
vilaprisan
5
Norethindrone Acetate
5
Mifepristone
5
ulipristal
4
linzagolix
4
Leuprolide
4
Tranexamic Acid
3
Sodium Chloride
3
Hysterectomy
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Saline Solution
2
Radiofrequency Ablation
2
Progestins
2
Lidocaine
2
Letrozole
2
Goserelin
2
Endometrial Ablation Techniques
2
Anesthesia, General
2
pirfenidone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leiomyoma
×
Vitamin B 6
×
Clear all
NCT05409872
2026-05-05
DEFIB
Universita di Verona
Phase NA
Completed
108 enrolled